CN Patent

CN115385896B — 一种csf-1r抑制剂中间体或其酸式盐的制备方法

Assigned to Abbisko Therapeutics Co Ltd · Expires 2024-11-15 · 2y expired

What this patent protects

本发明涉及一种CSF‑1R抑制剂中间体或其酸式盐的制备方法。所述制备方法以2‑氯‑4‑氟吡啶或其酸式盐为原料，经三步反应制备得到。本发明制备方法原料易得，操作简单，各步收率相对现有技术有很大提高，且工艺稳定，可适应工业化生产需求，解决药物可及性问题，有利于加速CSF‑1R抑制剂的临床开发和药物上市。

USPTO Abstract

本发明涉及一种CSF‑1R抑制剂中间体或其酸式盐的制备方法。所述制备方法以2‑氯‑4‑氟吡啶或其酸式盐为原料，经三步反应制备得到。本发明制备方法原料易得，操作简单，各步收率相对现有技术有很大提高，且工艺稳定，可适应工业化生产需求，解决药物可及性问题，有利于加速CSF‑1R抑制剂的临床开发和药物上市。

Drugs covered by this patent

Patent Metadata

Patent number
CN115385896B
Jurisdiction
CN
Classification
—
Expires
2024-11-15
Drug substance claim
No
Drug product claim
No
Assignee
Abbisko Therapeutics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.